Eplerenone in Patients with Systolic Heart Failure and Mild Symptoms
Authors
Faı̈ez Zannad•Henry Krum•Bertram Pitt
Journal
New England Journal of Medicine
Published
November 14, 2010
Abstract
Mineralocorticoid antagonists improve survival among patients with chronic, severe systolic heart failure and heart failure after myocardial infarction. We evaluated the effects of eplerenone in patients with chronic systolic heart failure and mild symptoms.